CaCO 3 nanoparticles are very suitable as intelligent carriers because of their ideal biocompatibility and biodegradability, especially their sensitivity to pH. In this paper, we use mesoporous CaCO 3 nanoparticles as intelligent carrier, sodium alginate, and chitosan as alternating assembly materials, folic acid as target molecules, and exploit layer-by-layer assembly technology to achieve sensitive molecular targeting and pH response drug release. Mesoporous CaCO 3 hybrid nanoparticles have high drug loading on doxorubicin. e e ects of di erent pH values on drug release in vitro were studied by regulating simulated body uids with di erent pH values. e cytotoxicity, targeting e ect, and drug release of human cervical cancer cell line (HeLa) were studied by cell vitality and imaging experiments. All the evidence suggests that the smart mesoporous CaCO 3 nanoparticles may be a potential clinical application platform for cancer therapy.
Introduction
In cancer treatment, because anticancer drugs alone cannot distinguish cancerous cells from healthy cells, serious side e ects are almost inevitable [1] [2] [3] . In order to overcome these problems, a variety of intelligent drug delivery systems have been developed to improve the e ciency of drug delivery [4] [5] [6] . Various stimulation strategies, including light irradiation [7, 8] , ion intensity [9, 10] , redox potential [11] , temperature [12] , enzymology [13] and pH [14] [15] [16] [17] have been developed for those drug delivery systems. Among them, pH response strategy has attracted special interest because of its ability to develop the acidic environment of cancerous tissues [18] . e pH value in tumor tissue (5.7-7. 2) is lower than that in blood and normal tissue, and the pH value of endosome and lysosome is even lower (5.0-5.5) [19] .
Calcium carbonate (CaCO 3 ) is an important biological mineral, which has attracted great attention in biomedical applications [20] . Compared with many other inorganic materials widely used in controlled transportation systems in the past, CaCO 3 nanosphere is very suitable as a non-toxic natural biological mineral because of its ideal biocompatibility, biodegradability and especially natural pH sensitivity [21] [22] [23] [24] [25] . So far, crystal CaCO 3 also shows promising potential for developing intelligent vectors for drugs, genes, and proteins [6, [26] [27] [28] [29] [30] [31] . However, the previously developed CaCO 3 mixed particles are usually crystal solid spheres with smaller BET surfaces, and the larger BET surface area can greatly improve the ability to load drug molecules, regardless of their surface charge and hydrophilicity. e study of small particle size CaCO 3 mesoporous nanoparticles (MCNs) with nanometer mesoporous nanoparticles as drug carrier is rarely reported.
In recent years, layer-by-layer (LbL) technology based on alternating adsorption of charged substrate has remained attractive to fabricate pH responsive delivery because of its unique characteristics [22, 26, 31] , including mild preparation conditions and easy customization (such as thickness, size and variable wall material). e targeted absorption of speci c cells can also be realized by functionalizing the surface of the carrier by using biological targeting molecules (folic acid or antibodies, etc.) because it has mild manufacturing conditions and is easy to customize its characteristics [32, 33] .
In this paper, the nanometer scale MCNs with pH responsive and molecular targeting functional as smart drug carriers were fabricated by the LbL self-assembly technique with sodium alginate (SA) and chitosan (CS) as the alternate assembling materials and surface modi cation with Polyethylene glycol (PEG) and targeting molecules (Figure 1 ), folic acid (FA), which is widely used as a speci c targeting molecule for cancer cell [34] [35] [36] . e controlled release of drugs from mixed mesoporous CaCO 3 nanoparticles was studied in vitro by adjusting the simulated body uids at di erent pH values. Cell vitality and imaging experiments were carried out to investigate the cytotoxicity, targeting and drug release e ect of human cervical cancer cell line (HeLa).
Materials and Methods
2.1. Chemicals and Materials. CaCl 2 , Na 2 CO 3 , Doxorubicin Hydrochloride (DOX) and soluble starch were obtained by Shanghai Aladdin reagent Co., Ltd, China. Chitosan (CS) was purchased by Golden-Shell Biochemical Co., Ltd. Zhejiang, China. Sodium alginate (SA) and glutaraldehyde (GA) were obtained from Shanghai Sangon. Biotech. Co. N-hydroxysuccinimide (NHS) and N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC·HCl) were purchased from Sigma-Aldrich Co., Ltd. All chemicals were directly used as received without further puri cation. NH 2 -PEG-NH 2 was purchased from Beijing Kaizheng Biological Engineering Development Co. Ltd. Millipore water (18.2 MΩ·cm at 25°C) was used throughout all of the experiments.
Preparation of Hierarchical Mesoporous CaCO 3 Nanoparticles (MCNs). Mesoporous CaCO 3 nanoparticles
were prepared and then functionalized by LbL technique. In brief, using CaCl 2 (0.5 M), Na 2 CO 3 (0.5 M) and soluble starch (5 wt%) as raw materials, CaCl 2 and soluble starch solution was prepared in a beaker and stirred for 30 min. Under strong stirring, Na 2 CO 3 solution was injected into the mixed solution quickly. e system was stirred for 10 min, beakers were covered, rested for 24 hours, and then the product was collected by centrifugation. In this experiment, the nal concentration of CaCl 2 and Na 2 CO 3 was the same, and the nal concentration of soluble starch was 1.25 wt%. e total volume of the reaction system is 400 mL.
Characterizations of MCNs.
Transmission electron microscope (TEM) samples were prepared by dripping the samples dispersed in water into the carbon-coated copper gate evaporated by excess solvent. Tem images were recorded on JEOL JEM-1200 EX and the acceleration voltage was 100 kV. e surface analysis was carried out by ASAP 2020 adsorption analyzer at 77 K. e speci c surface area is calculated by Brunauer-Emmett-Teller (BET) method and the pore size distribution is calculated by Barrett-Joyner Halenda (BJH) method. UV-vis spectra was obtained by Perkin Elmer Lambda 750 UV-vis spectrophotometer. Fourier transform infrared spectroscopy (FTIR) is provided by Nicolet Company of Nicolet Company.
DOX Loading into MCNs. Doxorubicin hydrochloric acid
can be easily encapsulated in MCNs. e adsorption capacity of DOX-MCNs in hydrochloric acid solution (pH = 1) was determined at 486 nm. A er DOX is unloaded in the medium, it can be directly used for the next batch of equivalent DOX. e drug loading and entrapment e ciency was calculated according to the following formula:
Layer-By-Layer Functionalized DOX-MCNs.
e multilayer hybrid-coated mesoporous CaCO 3 nanoparticles were prepared by means of LBL assembly technique. e rst step of the CaCO 3 nano-particle coating is to deposit a polyelectrolyte multilayer lm (CS/SA/CS) on the CaCO 3 template. e outermost layer of the CaCO 3 nanoparticles is a cationic polyelectrolyte CS to positively charge the surface of the particles. e composite multilayer lm was established by the electrostatic interaction between the negatively charged CaCO 3 nanoparticles and the polycation CS, and 200 mg of the CaCO 3 nanoparticles were dispersed in 40 mL of deionized water and 100 mg of CS was added for 1 h. And a er three times of centrifugation and water washing, the CS, the deacetylation degree and the molecular weight are 96% and 6.0 × 10 5 , are respectively deposited on the CaCO 3 nanoparticles to obtain the hybrid composite particles. e solution was then incubated for 60 min with 40 mL of SA (0.25% distilled water, viscosity 350 cps, 1 mg·mL −1 solution) and then centrifuged and dried. A multi-layer assembly consisting of 1 to 6 layers of CS/SA was prepared by continuous adsorption of two polyelectrolytes.
Folate-Conjugated DOX-MCNs.
e surface of the mixed composite CaCO 3 nanoparticles was modi ed using bifunctional PEG. Brie y, about 200 mg of the above-prepared mixed composite CaCO 3 nanoparticles were dispersed in 25 mL of deionized water, and 1.5 mL of 1% glutaraldehyde (GA) was added to introduce the functional group. A er the mixture was centrifuged and washed three times with water, 50 mg of NH 2 -PEG-NH 2 was used with stirring at room temperature for 24 hours, and then 5 mL of sodium borohydride (2.0 mg· mL −1 ) was added to the suspension. About 65 mg (0.15 mmol) of FA was dissolved in 2.5 mL of dimethyl sul de oxide (DMSO).
(1) en 40 mg of n-hydroxysuccinate (NHS) and 30 mg of N-(3dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride (EDC·HCl) was then added to the solution to activate the COOH group of the FA. e nal molar ratio of FA/NHS/EDC was 1 : 2.2 : 1.1. e solution was then added to the suspension. A er 24 hours, the free FA was removed by centrifugation and washed several times.
Size and Zeta Potential Measurements.
e size and zeta potential of the prepared nanoparticles were measured by Zeta sizer (Nano ZS 90, Malven instrument). Before determination, deionized water (800 L) was added to 200 L solution containing nanoparticles for dilution. e data are mean ± standard deviation (SD).
In Vitro Controlled Drug Release.
In vitro drug release experiment, 10 mg of folic acid conjugated and PEG modified DOX-MCNs powder were dispersed into 2 mL of deionized water. The dispersed solution was transferred to the dialysis bag (cut off molecular weight 7000), and then the bag was immersed in PBS solution of different 100 mL of pH (5.4, 6.4 and 7.4) at 37°C. At a certain interval, the solution of equal sample (1.0 mL) is taken, and then the same volume of fresh PBS solution is supplied. The amount of drugs released was measured by ultraviolet spectrophotometer.
Evaluation of In Vitro Cancer Cell Inhibition
2.9.1. MTT Assays. According to the previous report [37, 38] , the cell viability of the functionalized DOX-MCNs mesoporous carrier was assessed using the MTT cell analysis. HeLa cells were cultured in DMEM supplemented with 10% fetal bovine serum (FBS), penicillin (100 units· mL −1 ), streptomycin (100 mg·mL −1 ) and 5% CO 2 . e viability of the cells was analyzed using 3 [4,5-dimethyl-[2-based] 2,5-diphenyltetrabromobenzie (MTT, Sigma). e test was conducted in triplicate in the following manner, and the control experiment received without the MCNs vector and DOX was considered to be 100% growth. e cells were then incubated with DOX-loaded MCN with di erent concentrations, no drug MCN, and free DOX. About 1 mL of the complete medium and MTT (60 L, 5 mg·mL −1 ) were then added to each well and then incubated at 37°C for 4 hours, then the supernatant was carefully removed and 250 L of DMSO was added to each well to dissolve the formazan crystals produced by viable cells. e absorbance of the solution was measured at 570 nm using a microplate reader (BioR550) to determine the OD value. e cell survival rate is calculated as follows:
where the OD treated was obtained from cells treated with a speci c reagent, the OD control was obtained from the cells without any treatment, and the OD blank was obtained from only the culture and the reagent solution. Based on three independent measurements, the data is given as mean ± standard deviation (SD). Figure 2 (b) shows the Fourier transform infrared spectroscopy (FT-IR) of pure MCNs and di erent coating procedures. Compared with the MCNs prepared by SA, the FT-IR spectra of CS and SA functionalized MCNs have a new peak at 1110 cm −1 , which is related to the stretching vibration of C-O-C. In addition, a new peak of symmetrical tensile vibration of C-N appeared at 1230 cm −1 , which con rmed the successful functionalization of NH 2 -PEG-NH 2 group. A er gra ing with FA, a new adsorption peak appeared at 1735 cm −1 , which could be attributed to the stretching vibration of C=O, indicating that the gra ing of FA was successful. e dynamic light scattering (DLS) data indicate that the hydrodynamic size of the multi-layer assemblied CaCO 3 (FA/PEG/SA/CS-MCNs) in the aqueous solution is about ~300 nm. In addition, its stability is evaluated by monitoring its hydrodynamic size in a complete cell culture medium containing 10% FBS, as shown in Figures S2, S3 , S4 (support information). e dynamic size of the multi-layer coated MCNs did not change signi cantly within 96 h, indicating that these nanospheres were relatively stable in the biological uid at physiological pH values, so that they were further applied in the biological system.
It is well known that the CaCO 3 can be decomposed in an acidic medium. e pH sensitivity of the multi-layer coating MCNs was tested by soaking in bu er at di erent pH values (5.4, 6.4, and 7.4) . Under the condition of pH 7.4, the MCNs solution did not change signi cantly within 2 hours, whereas in the mild acid bu er of pH 6.4, the corresponding MCNs solution was gradually clear a er 2 h, and more importantly, the MCNs solution was rapidly clear at pH 5.5, indicating the sensitive pH value responsibility of the nano-particles. In addition, the change of the hydrodynamic size of the nanoparticles with time at di erent pH, further con rmed the pH sensitivity of the DLS to the MCNs. As shown in Figure 3 , the 2.9.2. Cell Imaging. In order to check the cell uptake and DOX release of the functionalized DOX-MCN, HeLa cells were cultured in a 12-well slider with a cover glass at the bottom of each chamber in a medium (DMEM) and incubated in cultured medium containing 200 μg·mL −1 of the nanocomposites at 37°C. A er removal of the medium, the cells were washed three times with PBS (pH = 7.4) and the cover glass was observed under a laser scanning confocal microscope (TCSP5, Leica).
Results and Discussions

Characterization of Layer-By-Layer Assembled Hierarchical Mesoporous CaCO 3 Nanoparticles.
e preparation and subsequent layer-by-layer assembly of layered mesoporous CaCO 3 nanoparticles are shown in Figure 2 . Firstly, nanosized mesoporous CaCO 3 nanoparticles were synthesized. e prepared MCNs exhibited a high surface area of 208 m 2 ·g −1 and pore diameter of 11 nm as shown in Figure S1 (supporting information), indicating their mesoporous structure which may be helpful for the subsequent drug loading and controllable release.
LBL self-assembly technique was used to prepare coated multi-layer mixed nanoparticles by alternating adsorption of anion polyelectrolyte alginate (SA), cationic polyelectrolyte (CS) and anion layered MCNS by electrostatic interaction. e Zeta potential of the composite nanoparticles was carried out to track the polyelectrolyte multilayer coating, as shown in Figure 2 (a). e Zeta potential of the pure prepared MCNs is −7.47 mV, and the negative charge on the surface of the nanoparticles is used as the hybrid anion in the process of LBL self-assembly. When the rst layer of CS is deposited on the MCNs template, the zeta potential is about 23.43 mV, and the second layer of SA is −7.14 mV. It can be proved that the change of polyelectrolytes is adsorbed on the surface of MCNs template. We also note that when the number of layers of coated polyelectrolytes exceeds 5, the positive and negative potentials on the surface of nanoparticles are more than 20 mV. It is generally believed that the potential above the surface 20 mV will stabilize the nanoparticles in the solution, which indicates that polyelectrolyte deposition can improve the dispersion and stability in water [39, 40] . Considering that more polyelectrolyte (CS/SA) deposits induce larger hydrodynamic dimensions, ve layers of polyelectrolytes are used as the best deposition and further research. When combined with functional NH 2 -PEG-NH 2 , the zeta potential of polyelectrolyte DOX-MCNs at various pH values (5.4, 6.4, 7.4) was then measured, as shown in Figure 4 . As expected, the release of DOX was signi cantly pH-dependent, no signi cant release was observed at a physiological pH (7.4) of 37°C, but under mild acid conditions, the drug was released from the carrier to a large amount of the external environment. e cumulative release of DOX can reach 92% at pH 5.5 a er 2 h, which is much higher than that of pH 6.4 (50%) and 7.4 (13%), respectively.
Cellular Uptake.
e feasibility of pH-responsive MCNs for DOX administration was evaluated with HeLa cells. As shown in Figure 5 , strong red DOX uorescence signals emerged inside cells a er incubation with DOX-MCNs, suggesting the e cient cellular uptake of our nanoparticles. A er 4 hours of co-culture, DOX was released from the vector and then concentrated rapidly in the nuclei region, consistent with previous reports [41, 42] . ese results suggest that DOXloaded MCNs can speci cally respond to drug release in the pathological microenvironment in a pH response manner.
Targeting Function and In Vitro Cytotoxicity of the
MCNs. In order to evaluate the FA-mediated targeting of polyelectrolytes (MCNs), the polyelectrolytes hybrid MCNs with FA-containing DOX loading and the DOX-loaded hybrid MCNs without FA were compared. As shown in Figure 6 , the introduction of DOX results in a decrease in cell viability with the DOX concentration increases. In addition, the DOX-loaded FA-targeted polyelectrolytes hybrid MCNs exhibit a signi cant cell-inhibitory e ect than only the PEGmodi ed MCNs, suggesting that this inhibition is mainly due to the acid-mediated targeting of the cells of the mesoporous microspheres [26, 27, 43] . e cytotoxicity of DOX loaded polyelectrolyte hybrid mesoporous nano-spheres in vitro was also studied in HeLa cells. Figure 7(a) shows the viability of HeLa cells incubated with di erent concentrations of functional MCNs within 24 hours. It was clearly observed that even a er 72 hours, the viability of HeLa cells in all doses was as high as 91.0-102.5%, hydrodynamic size of the multi-layer coated MCNs dispersion bu er was not signi cantly changed under the condition of neutral pH 7.4, and the particle size of the nanoparticles decreased in a time-dependent manner at pH 6.4, indicating that the dissociation of the MCNs was slow, while at pH 5.4, the dissociation process was signi cantly accelerated.
High Drug Loading E ciency.
MCNs have a mesoporous structure and can be used for drug loading. Doxorubicin (DOX), a commonly used anticancer drug, was selected as the model drug and DOX was adsorbed on porous CaCO 3 nanoparticles. Table 1 shows that the DOX loading of MCNs increases rapidly with the increase of "DOX/MCNs" at di erent weight ratios of "DOX/MCNs", up to 108.9 mg·g −1 at "DOX/MCNs" = 0.8. e results showed that the carrier had a high drug loading on DOX.
DOX Release of the Multiple Layer Coating DOX-MCNs.
e DOX release from the multi-layer coating condition of micro-acid, the MCNs are rapidly degraded, resulting in the e ective release of DOX. e nano-particles are co-cultured with HeLa cells, and the cell uptake e ciency is high, the cytotoxicity is low, and the molecular targeting property is strong. Considering the inherent biocompatibility and biodegradability of the CaCO 3 , as well as the sensitive reaction to the pH value and the molecular target of the tumor, the prepared hybrid MCNs is a promising intelligent nano-drug delivery platform, and has a large clinical application prospect.
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indicating that the multi-layer coated MCNs vectors without DOX drugs showed very low cytotoxicity. In the case of free DOX, the rapid insertion of DNA base pairs into nucleic acid [44, 45] resulted in cell killing (Figures 7(b)-7(d) ). e pH response of DOX-MCNs a er cell uptake determines the continuous killing e ect in intracellular physiological environment. In addition, the cell activity treated with these nanoparticles showed typical time-dependent cell death (Figures 7(b)-7(d) ).
Conclusion
In summary, we successfully developed a multifunctional nano-carrier with a pH response and a molecular targeting function, which is a single-dispersion nanoscale MCNs modied with the LBL self-assembly technology by using SA and CS as an alternative assembly material to target the molecular FA as a surface modi er. Under the physiological pH value of 7.4, the multi-layer coating MCNs-DOX is stable, while under the 
